戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ritical role in the inflammatory response to Gram-positive bacterial infection.
2 ammatory responses of primary macrophages to Gram-positive bacterial infection.
3 ammatory response and host defense against a gram-positive bacterial infection.
4 pposed to protective, role for IL-17A during Gram-positive bacterial infections.
5 ration of novel vaccine modalities to combat Gram-positive bacterial infections.
6 rt for the treatment of antibiotic-resistant gram-positive bacterial infections.
7 in is an important drug for the treatment of Gram-positive bacterial infections.
8 peptide antibiotic used for the treatment of Gram-positive bacterial infections.
9 ceptible to Gram-negative (E. coli), but not Gram-positive, bacterial infection.
10 he primary TLR2 ligand in the early phase of gram-positive bacterial infection and remains a major li
11         dawdle, in contrast, is activated by Gram-positive bacterial infection but repressed by Gram-
12 the treatment of serious multidrug-resistant Gram-positive bacterial infections caused by strains of
13 line antibiotic to treat multidrug-resistant Gram-positive bacterial infections, e.g., methicillin-re
14                Although the role of MCP-1 in gram-positive bacterial infections has been previously i
15  results show that MC confer defense against Gram-positive bacterial infection in the skin, a functio
16  earliest steps in innate immune response to Gram-positive bacterial infection is poorly understood.
17                   However, its role in other Gram-positive bacterial infections is unclear.
18 infective agents in the treatment of serious gram-positive bacterial infections, their usefulness is
19    The findings of this study suggest that a Gram-positive bacterial infection, through TLR2 and TLR1
20 e the physiological function of MKP-1 during Gram-positive bacterial infection, we studied the innate

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。